AzTrials
AzTrials

AgingMIPAMNCT03906162

A 12-week Intervention With Motivational Interviewing and Physical Activity Monitoring, to Enhance the Daily Amount of Physical Activity in Community Dwelling Older Adults - a Randomized Controlled Trial

A study testing Motivational interviews and Base intervention in people with Aging and Physical Activity, run by University of Copenhagen at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To investigate if motivational-interviewing will enhance the expected effect from physical activity monitors, on physical activity in older adults, we will conduct a two-arm randomized controlled trial in 2019. Read more about this study

Who is it for?
Ages 70 years and olderHealthy volunteers can take part
Conditions the study is for
Aging, Physical Activity, Older Adults
What is being tested?
Motivational interviews and Base intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
65 participants
Where
1 siteDenmark
Study dates
4 Apr 2019to 15 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Participants must:
  • Be minimum 70 years of age at the time of inclusion
  • Own and use an Apple/Google/Microsoft smartphone device compatible with the Garmin Connect™ Mobile application.
  • Own use an e-mail account
  • Live in Denmark and have a Danish postal address and be able to receive the intervention content.
  • Be able to walk independently with or without assistive devices.

Who cannot join

  • Participants cannot
  • Receive active cancer treatment
  • Have major cognitive impairment (e.g. dementia or alzheimers).
  • Parkinson's or Multiple Sclerosis (or similar disease) affecting their mobility in such a way that the participants cannot walk on a daily basis.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Rasmus Tolstrup

    Copenhagen, 1663

Other trials in Denmark

About this study

To investigate if motivational-interviewing will enhance the expected effect from physical activity monitors, on physical activity in older adults, we will conduct a two-arm randomized controlled trial in 2019.

Both groups in the trial will receive a physical activity monitor for everyday use in the 12-week intervention period and a folder with information about the benefits of physical activity in older age. Participants in the intervention group will in addition to the use of the physical activity monitors receive a motivational feedback session by phone of about 20 minutes constructed from the theoretical framework of Motivational interviewing by Rollnick, Miller \& Butler and Social Cognitive Theory by Bandura. The content of the session focuses on investigating the most relevant possibilities and barriers for the participant to increase his or her levels of PA.

The primary outcome will be between group difference in average steps per day throughout the intervention period, measured objectively by the physical activity monitor (Garmin Vivofit 3). Secondary outcomes include participant reported outcome measures such as 'International Physical Activity Questionnaire', 'Nordic Physical Activity Questionnaire', 'EQ5D Quality of life questionnaire', 'UCLA Loneliness Scale', 'Self Efficacy for Exercise', and 'Outcome expectancy for Exercise'. To ensure 80% power with an alpha-level on 0.05, we will include 128 participants. The study will enroll in March 2019.

Being tested
Motivational interviews, Base intervention
Keywords
physical activity monitors, motivational interviewing, walking, fitness-tracker, social cognitive theory, older age
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motivational interviewsBehavioural

    During the 12-week intervention, the participants will receive seven telephone calls from a physical therapist. The interviews will be held in week 1, 2,3,5,7,9, and 12.

    The telephone call will consist of a motivational interview focused on enhancing the daily level of physical activity in the participants.

    MI is a form of counselling aiming at prompting increases in self-efficacy, which may leave people more open to and invested in changing their behaviours and shows potential for significant effects for exercise behaviour change.

    In addition to the telephone based motivational interviews, the experimental group will also receive the "base intervention" which is described in detail under the "control intervention paragraph".

  • Base interventionBehavioural

    The "base intervention" consists of a physical activity monitor (PAM) for everyday use in the intervention period and a pamphlet with information about Danish recommendations on physical activity in aging populations. The PAM will be the Garmin Vivofit 3 monitor linked to a pre-specified Garmin Connect account. The participants will be asked to install the Garmin Connect application on their smartphone and use the given ID/password in the app. The participants will be asked to wear the monitor 24-hours a day for the 12-week intervention period. The participants can use the PAM as they like but they will be asked to try to use the PAM and the application to enhance their daily level of physical activity.

Study groups in NCT03906162
Study groupRoleWhat they receive
Motivational interviewingExperimentalExperimental content + base intervention
Receives: Behavioral: Motivational interviews; Behavioral: Base intervention
Control interventionActive comparatorBase intervention
Receives: Behavioral: Base intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Individual intervention period average of PAM measured steps per day

    Daily step counts will be objectively measured by the PAM.

    Measured: A daily average of the 12 weeks of intervention

Secondary outcomes (6)
  1. International Physical Activity Questionnaire

    Questionnaire: The seven-item IPAQ-SF measure assesses the types of intensity of physical activity and sitting time that people has done the past seven days as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting.

    Measured: Baseline + end point at 12 weeks + follow up at 6 months and 12 months

  2. Nordic Physical Activity Questionnaire

    Questionnaire: It is developed to monitor compliance with the WHO recommendations on PA.

    Measured: Baseline + end point at 12 weeks + follow up at 6 months and 12 months

  3. EQ5D Quality of life questionnaire

    Questionnaire: The EQ-5D-5L is a generic health-related quality of life (HRQoL) measure developed as a non-disease-specific instrument for describing and valuing health states and comprises five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), each of which has three levels (no problems, moderate problems and extreme problems) and a visual analogue scale (EQ VAS). The score for the five dimensions can be combined into a five-digit number that describes the patient's health state. The EQ VAS records the patient's self-rated health on a vertical visual analogue scale, where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'.

    Measured: Baseline + end point at 12 weeks + follow up at 6 months and 12 months

  4. University of California, Los Angeles, Loneliness Scale

    Questionnaire: The 20-item UCLA loneliness scale (third version) is a self-report measure of loneliness and social isolation. The scale consists of 11 positive and nine negative items and the total score is calculated by finding the sum of 20 items (0-60), with a higher score indicating more loneliness.

    Measured: Baseline + end point at 12 weeks + follow up at 6 months and 12 months

  5. Self Efficacy for Exercise

    Questionnaire: The nine-item SEE-DK addresses confidence to engage in regular exercise [44], when challenged by known barriers to exercise. The scale was developed initially for sedentary adults in the community who participated in an outpatient exercise program and was revised to older adults. It is designed to be administered using face-to-face interview. Response categories range from 0 (no confidence) to 10 (very confident). Item scores are used to calculate a total score (0-90), with higher scores indicating higher confidence, or self-efficacy, related to exercise. The SEE-DK is adapted to Danish older adults with acceptable face and content validity, construct validity by acceptable model fit as a unidimensional scale, and test-retest reliability.

    Measured: Baseline + end point at 12 weeks + follow up at 6 months and 12 months

  6. Outcome expectancy for Exercise

    Questionnaire: The 13-item OEE-2 scale was developed from the original 9-item Outcome Expectations for Exercise scale (OEE) that specifically focused on measuring the positive outcome expectations for exercise (POEE). To complete the OEE2-DK scale the participants are asked, using a Likert scale, to strongly agree, agree, neither agree nor disagree, disagree, or strongly disagree with the stated outcomes to each statement of exercising.

    Measured: Baseline + end point at 12 weeks + follow up at 6 months and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2019
  2. Study start4 Apr 2019
  3. Primary completion15 Mar 2020
  4. Study completion15 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
12 week intervention with two groups in a parallel design
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
65 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03906162
Sponsor's protocol ID
18004960
Acronym
MIPAM
Status last verified
Oct 2020
First submitted
1 Apr 2019
Last updated
8 Oct 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Fully anonymised data set will be published with the published paper

Publications

  • Larsen RT, Korfitsen CB, Keller C, Christensen J, Andersen HB, Juhl C, Langberg H. The MIPAM trial - motivational interviewing and physical activity monitoring to enhance the daily level of physical activity among older adults - a randomized controlled trial. Eur Rev Aging Phys Act. 2021 Jul 2;18(1):12. doi: 10.1186/s11556-021-00269-7.

    PubMed 34215176
  • Larsen RT, Korfitsen CB, Juhl CB, Andersen HB, Christensen J, Langberg H. The MIPAM trial: a 12-week intervention with motivational interviewing and physical activity monitoring to enhance the daily amount of physical activity in community-dwelling older adults - a study protocol for a randomized controlled trial. BMC Geriatr. 2020 Oct 20;20(1):412. doi: 10.1186/s12877-020-01815-1.

    PubMed 33081715

Questions about this trial

What is this clinical trial studying?

A study testing Motivational interviews and Base intervention in people with Aging and Physical Activity, run by University of Copenhagen at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Individual intervention period average of PAM measured steps per day (time frame: A daily average of the 12 weeks of intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03906162, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
MIPAM Clinical Trial NCT03906162 | AzTrials